OrbiMed Capital GP III LLC, Director at AMARIN CORP PLC\UK (AMRN), sold 800,000 shares at $15.79 ($12.6M) on 2011-04-20, disclosed to the SEC on 2011-04-26.
Scheduled sale ($12.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.79 | 7,600 | $120K | 0.9% |
| 2 | $15.79 | 792,400 | $12.5M | 99.1% |
| Total | $15.79 avg | 800,000 | $12.6M | 100% |
| Filing → |
| VRAY | SELL | 2018-08-07 | $3.8M | — | Filing → |
| PIRS | SELL | 2018-02-15 | $141K | — | Filing → |
| PIRS | SELL | 2017-12-20 | $842K | — | Filing → |